SIC 5912 – Drug Stores and Proprietary Stores
Valuation | |
---|---|
Market Cap ($M) | 70,181.39 |
Enterprise Value ($M) | 127,629.39 |
Book Value ($M) | 75,106.00 |
Book Value / Share | 59.68 |
Price / Book | 0.93 |
NCAV ($M) | -109,978.00 |
NCAV / Share | -87.39 |
Price / NCAV | -0.64 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.07 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.59 |
Current Ratio | 0.80 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 67,343.00 |
Assets | 252,427.00 |
Liabilities | 177,321.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Dodge & Cox | 5.00 | ||
13G/A | BlackRock, Inc. | 8.30 | ||
13G/A | Vanguard Group Inc | 9.14 | 0.13 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,473,692 | 9,306,465 | 15.84 | |
1,220,995 | 8,559,543 | 14.26 | |
2,201,084 | 11,671,298 | 18.86 | |
1,457,417 | 12,657,114 | 11.51 | |
(click for more detail) |